<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1988-01-01" modified="2020-10-07" version="226">
<accession>P06702</accession>
<accession>D3DV36</accession>
<accession>Q6FGA1</accession>
<accession>Q9NYM0</accession>
<accession>Q9UCJ1</accession>
<name>S10A9_HUMAN</name>
<protein>
<recommendedName>
<fullName>Protein S100-A9</fullName>
</recommendedName>
<alternativeName>
<fullName>Calgranulin-B</fullName>
</alternativeName>
<alternativeName>
<fullName>Calprotectin L1H subunit</fullName>
</alternativeName>
<alternativeName>
<fullName>Leukocyte L1 complex heavy chain</fullName>
</alternativeName>
<alternativeName>
<fullName>Migration inhibitory factor-related protein 14</fullName>
<shortName>MRP-14</shortName>
<shortName>p14</shortName>
</alternativeName>
<alternativeName>
<fullName>S100 calcium-binding protein A9</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">S100A9</name>
<name type="synonym">CAGB</name>
<name type="synonym">CFAG</name>
<name type="synonym">MRP14</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1987" name="Nature" volume="330" first="80" last="82">
<title>Two calcium-binding proteins in infiltrate macrophages of rheumatoid arthritis.</title>
<authorList>
<person name="Odink K."/>
<person name="Cerletti N."/>
<person name="Bruggen J."/>
<person name="Clerc R.G."/>
<person name="Tarcsay L."/>
<person name="Zwaldo G."/>
<person name="Gerhards G."/>
<person name="Schlegel R."/>
<person name="Sorg C."/>
</authorList>
<dbReference type="PubMed" id="3313057"/>
<dbReference type="DOI" id="10.1038/330080a0"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1988" name="Mol. Cell. Biol." volume="8" first="2402" last="2410">
<title>Cloning and expression of two human genes encoding calcium-binding proteins that are regulated during myeloid differentiation.</title>
<authorList>
<person name="Lagasse E."/>
<person name="Clerc R.G."/>
</authorList>
<dbReference type="PubMed" id="3405210"/>
<dbReference type="DOI" id="10.1128/mcb.8.6.2402"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1989" name="J. Biol. Chem." volume="264" first="8356" last="8360">
<title>A protein containing the cystic fibrosis antigen is an inhibitor of protein kinases.</title>
<authorList>
<person name="Murao S."/>
<person name="Collart F.R."/>
<person name="Huberman E."/>
</authorList>
<dbReference type="PubMed" id="2656677"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>BLOCKAGE OF N-TERMINUS</scope>
</reference>
<reference key="4">
<citation type="submission" date="2000-02" db="EMBL/GenBank/DDBJ databases">
<title>Human gene for migration inhibitory factor-related protein 14 (MRP14), variant allele.</title>
<authorList>
<person name="Wang M."/>
<person name="Xu X."/>
<person name="Cai Y."/>
<person name="Xu H."/>
<person name="Han Y."/>
<person name="Xu Z."/>
<person name="Wu M."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANT ARG-20</scope>
</reference>
<reference key="5">
<citation type="submission" date="2004-06" db="EMBL/GenBank/DDBJ databases">
<title>Cloning of human full open reading frames in Gateway(TM) system entry vector (pDONR201).</title>
<authorList>
<person name="Halleck A."/>
<person name="Ebert L."/>
<person name="Mkoundinya M."/>
<person name="Schick M."/>
<person name="Eisenstein S."/>
<person name="Neubert P."/>
<person name="Kstrang K."/>
<person name="Schatten R."/>
<person name="Shen B."/>
<person name="Henze S."/>
<person name="Mar W."/>
<person name="Korn B."/>
<person name="Zuo D."/>
<person name="Hu Y."/>
<person name="LaBaer J."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2006" name="Nature" volume="441" first="315" last="321">
<title>The DNA sequence and biological annotation of human chromosome 1.</title>
<authorList>
<person name="Gregory S.G."/>
<person name="Barlow K.F."/>
<person name="McLay K.E."/>
<person name="Kaul R."/>
<person name="Swarbreck D."/>
<person name="Dunham A."/>
<person name="Scott C.E."/>
<person name="Howe K.L."/>
<person name="Woodfine K."/>
<person name="Spencer C.C.A."/>
<person name="Jones M.C."/>
<person name="Gillson C."/>
<person name="Searle S."/>
<person name="Zhou Y."/>
<person name="Kokocinski F."/>
<person name="McDonald L."/>
<person name="Evans R."/>
<person name="Phillips K."/>
<person name="Atkinson A."/>
<person name="Cooper R."/>
<person name="Jones C."/>
<person name="Hall R.E."/>
<person name="Andrews T.D."/>
<person name="Lloyd C."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ambrose K.D."/>
<person name="Anderson F."/>
<person name="Andrew R.W."/>
<person name="Ashwell R.I.S."/>
<person name="Aubin K."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Beasley H."/>
<person name="Bethel G."/>
<person name="Bird C.P."/>
<person name="Bray-Allen S."/>
<person name="Brown J.Y."/>
<person name="Brown A.J."/>
<person name="Buckley D."/>
<person name="Burton J."/>
<person name="Bye J."/>
<person name="Carder C."/>
<person name="Chapman J.C."/>
<person name="Clark S.Y."/>
<person name="Clarke G."/>
<person name="Clee C."/>
<person name="Cobley V."/>
<person name="Collier R.E."/>
<person name="Corby N."/>
<person name="Coville G.J."/>
<person name="Davies J."/>
<person name="Deadman R."/>
<person name="Dunn M."/>
<person name="Earthrowl M."/>
<person name="Ellington A.G."/>
<person name="Errington H."/>
<person name="Frankish A."/>
<person name="Frankland J."/>
<person name="French L."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Gay L."/>
<person name="Ghori M.R.J."/>
<person name="Gibson R."/>
<person name="Gilby L.M."/>
<person name="Gillett W."/>
<person name="Glithero R.J."/>
<person name="Grafham D.V."/>
<person name="Griffiths C."/>
<person name="Griffiths-Jones S."/>
<person name="Grocock R."/>
<person name="Hammond S."/>
<person name="Harrison E.S.I."/>
<person name="Hart E."/>
<person name="Haugen E."/>
<person name="Heath P.D."/>
<person name="Holmes S."/>
<person name="Holt K."/>
<person name="Howden P.J."/>
<person name="Hunt A.R."/>
<person name="Hunt S.E."/>
<person name="Hunter G."/>
<person name="Isherwood J."/>
<person name="James R."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Joy A."/>
<person name="Kay M."/>
<person name="Kershaw J.K."/>
<person name="Kibukawa M."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Knights A.J."/>
<person name="Lad H."/>
<person name="Laird G."/>
<person name="Lawlor S."/>
<person name="Leongamornlert D.A."/>
<person name="Lloyd D.M."/>
<person name="Loveland J."/>
<person name="Lovell J."/>
<person name="Lush M.J."/>
<person name="Lyne R."/>
<person name="Martin S."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L."/>
<person name="Matthews N.S.W."/>
<person name="McLaren S."/>
<person name="Milne S."/>
<person name="Mistry S."/>
<person name="Moore M.J.F."/>
<person name="Nickerson T."/>
<person name="O'Dell C.N."/>
<person name="Oliver K."/>
<person name="Palmeiri A."/>
<person name="Palmer S.A."/>
<person name="Parker A."/>
<person name="Patel D."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Pelan S."/>
<person name="Phelps K."/>
<person name="Phillimore B.J."/>
<person name="Plumb R."/>
<person name="Rajan J."/>
<person name="Raymond C."/>
<person name="Rouse G."/>
<person name="Saenphimmachak C."/>
<person name="Sehra H.K."/>
<person name="Sheridan E."/>
<person name="Shownkeen R."/>
<person name="Sims S."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Steward C."/>
<person name="Subramanian S."/>
<person name="Sycamore N."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Van Helmond Z."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="White S."/>
<person name="Whitehead S.L."/>
<person name="Wilkinson J.E."/>
<person name="Willey D.L."/>
<person name="Williams H."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Wu Z."/>
<person name="Coulson A."/>
<person name="Vaudin M."/>
<person name="Sulston J.E."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Wooster R."/>
<person name="Dunham I."/>
<person name="Carter N.P."/>
<person name="McVean G."/>
<person name="Ross M.T."/>
<person name="Harrow J."/>
<person name="Olson M.V."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Bentley D.R."/>
</authorList>
<dbReference type="PubMed" id="16710414"/>
<dbReference type="DOI" id="10.1038/nature04727"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Lung</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="1989" name="Nature" volume="342" first="189" last="192">
<title>Ionomycin-regulated phosphorylation of the myeloid calcium-binding protein p14.</title>
<authorList>
<person name="Edgeworth J."/>
<person name="Freemont P."/>
<person name="Hogg N."/>
</authorList>
<dbReference type="PubMed" id="2478889"/>
<dbReference type="DOI" id="10.1038/342189a0"/>
</citation>
<scope>PROTEIN SEQUENCE OF 84-114</scope>
<scope>PHOSPHORYLATION AT THR-113</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1989" name="Chem. Pharm. Bull." volume="37" first="1576" last="1580">
<title>Amino acid sequences of 60B8 antigens induced in HL-60 cells by 1,25-dihydroxyvitamin D3. The antigens are identical with macrophage-related protein-14 and -8.</title>
<authorList>
<person name="Tobe T."/>
<person name="Murakami K."/>
<person name="Tomita M."/>
<person name="Nozawa R."/>
</authorList>
<dbReference type="PubMed" id="2776242"/>
<dbReference type="DOI" id="10.1248/cpb.37.1576"/>
</citation>
<scope>PROTEIN SEQUENCE</scope>
<scope>BLOCKAGE OF N-TERMINUS</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1992" name="Electrophoresis" volume="13" first="960" last="969">
<title>Microsequences of 145 proteins recorded in the two-dimensional gel protein database of normal human epidermal keratinocytes.</title>
<authorList>
<person name="Rasmussen H.H."/>
<person name="van Damme J."/>
<person name="Puype M."/>
<person name="Gesser B."/>
<person name="Celis J.E."/>
<person name="Vandekerckhove J."/>
</authorList>
<dbReference type="PubMed" id="1286667"/>
<dbReference type="DOI" id="10.1002/elps.11501301199"/>
</citation>
<scope>PROTEIN SEQUENCE OF 11-19; 26-37 AND 94-107</scope>
<source>
<tissue>Keratinocyte</tissue>
</source>
</reference>
<reference key="12">
<citation type="journal article" date="1993" name="J. Dent. Res." volume="72" first="517" last="523">
<title>In vitro antimicrobial activity of the human neutrophil cytosolic S-100 protein complex, calprotectin, against Capnocytophaga sputigena.</title>
<authorList>
<person name="Miyasaki K.T."/>
<person name="Bodeau A.L."/>
<person name="Murthy A.R."/>
<person name="Lehrer R.I."/>
</authorList>
<dbReference type="PubMed" id="8423249"/>
<dbReference type="DOI" id="10.1177/00220345930720020801"/>
</citation>
<scope>PROTEIN SEQUENCE OF 5-34</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>IDENTIFICATION IN THE CALPROTECTIN COMPLEX</scope>
<scope>FUNCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1997" name="J. Biol. Chem." volume="272" first="9496" last="9502">
<title>Myeloid-related protein (MRP) 8 and MRP14, calcium-binding proteins of the S100 family, are secreted by activated monocytes via a novel, tubulin-dependent pathway.</title>
<authorList>
<person name="Rammes A."/>
<person name="Roth J."/>
<person name="Goebeler M."/>
<person name="Klempt M."/>
<person name="Hartmann M."/>
<person name="Sorg C."/>
</authorList>
<dbReference type="PubMed" id="9083090"/>
<dbReference type="DOI" id="10.1074/jbc.272.14.9496"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>SUBUNIT</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2001" name="Biochem. Biophys. Res. Commun." volume="289" first="191" last="197">
<title>The microbial receptor CEACAM3 is linked to the calprotectin complex in granulocytes.</title>
<authorList>
<person name="Streichert T."/>
<person name="Ebrahimnejad A."/>
<person name="Ganzer S."/>
<person name="Flayeh R."/>
<person name="Wagener C."/>
<person name="Bruemmer J."/>
</authorList>
<dbReference type="PubMed" id="11708798"/>
<dbReference type="DOI" id="10.1006/bbrc.2001.5955"/>
</citation>
<scope>INTERACTION WITH CEACAM3</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2003" name="J. Immunol." volume="170" first="3233" last="3242">
<title>Proinflammatory activities of S100: proteins S100A8, S100A9, and S100A8/A9 induce neutrophil chemotaxis and adhesion.</title>
<authorList>
<person name="Ryckman C."/>
<person name="Vandal K."/>
<person name="Rouleau P."/>
<person name="Talbot M."/>
<person name="Tessier P.A."/>
</authorList>
<dbReference type="PubMed" id="12626582"/>
<dbReference type="DOI" id="10.4049/jimmunol.170.6.3233"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2004" name="Blood" volume="104" first="4260" last="4268">
<title>MRP8 and MRP14 control microtubule reorganization during transendothelial migration of phagocytes.</title>
<authorList>
<person name="Vogl T."/>
<person name="Ludwig S."/>
<person name="Goebeler M."/>
<person name="Strey A."/>
<person name="Thorey I.S."/>
<person name="Reichelt R."/>
<person name="Foell D."/>
<person name="Gerke V."/>
<person name="Manitz M.P."/>
<person name="Nacken W."/>
<person name="Werner S."/>
<person name="Sorg C."/>
<person name="Roth J."/>
</authorList>
<dbReference type="PubMed" id="15331440"/>
<dbReference type="DOI" id="10.1182/blood-2004-02-0446"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH TUBULIN</scope>
<scope>PHOSPHORYLATION AT THR-113</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2005" name="Blood" volume="105" first="2955" last="2962">
<title>Myeloid-related proteins 8 and 14 induce a specific inflammatory response in human microvascular endothelial cells.</title>
<authorList>
<person name="Viemann D."/>
<person name="Strey A."/>
<person name="Janning A."/>
<person name="Jurk K."/>
<person name="Klimmek K."/>
<person name="Vogl T."/>
<person name="Hirono K."/>
<person name="Ichida F."/>
<person name="Foell D."/>
<person name="Kehrel B."/>
<person name="Gerke V."/>
<person name="Sorg C."/>
<person name="Roth J."/>
</authorList>
<dbReference type="PubMed" id="15598812"/>
<dbReference type="DOI" id="10.1182/blood-2004-07-2520"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2005" name="FASEB J." volume="19" first="467" last="469">
<title>The arachidonic acid-binding protein S100A8/A9 promotes NADPH oxidase activation by interaction with p67phox and Rac-2.</title>
<authorList>
<person name="Kerkhoff C."/>
<person name="Nacken W."/>
<person name="Benedyk M."/>
<person name="Dagher M.C."/>
<person name="Sopalla C."/>
<person name="Doussiere J."/>
</authorList>
<dbReference type="PubMed" id="15642721"/>
<dbReference type="DOI" id="10.1096/fj.04-2377fje"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH NCF2/P67PHOX; RAC1 AND RAC2</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2005" name="J. Immunol." volume="174" first="7257" last="7267">
<title>Myeloid-related protein-14 is a p38 MAPK substrate in human neutrophils.</title>
<authorList>
<person name="Lominadze G."/>
<person name="Rane M.J."/>
<person name="Merchant M."/>
<person name="Cai J."/>
<person name="Ward R.A."/>
<person name="McLeish K.R."/>
</authorList>
<dbReference type="PubMed" id="15905572"/>
<dbReference type="DOI" id="10.4049/jimmunol.174.11.7257"/>
</citation>
<scope>PHOSPHORYLATION AT THR-113</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2005" name="Mediators Inflamm." volume="2005" first="280" last="292">
<title>Regulation of S100A8/A9 (calprotectin) binding to tumor cells by zinc ion and its implication for apoptosis-inducing activity.</title>
<authorList>
<person name="Nakatani Y."/>
<person name="Yamazaki M."/>
<person name="Chazin W.J."/>
<person name="Yui S."/>
</authorList>
<dbReference type="PubMed" id="16258195"/>
<dbReference type="DOI" id="10.1155/mi.2005.280"/>
</citation>
<scope>FUNCTION</scope>
<scope>INHIBITION BY ZINC IONS</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2008" name="J. Biol. Chem." volume="283" first="31776" last="31784">
<title>Interaction between S100A8/A9 and annexin A6 is involved in the calcium-induced cell surface exposition of S100A8/A9.</title>
<authorList>
<person name="Bode G."/>
<person name="Lueken A."/>
<person name="Kerkhoff C."/>
<person name="Roth J."/>
<person name="Ludwig S."/>
<person name="Nacken W."/>
</authorList>
<dbReference type="PubMed" id="18786929"/>
<dbReference type="DOI" id="10.1074/jbc.m803908200"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH ANXA6</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2008" name="J. Proteome Res." volume="7" first="5167" last="5176">
<title>Phosphorylation analysis of primary human T lymphocytes using sequential IMAC and titanium oxide enrichment.</title>
<authorList>
<person name="Carrascal M."/>
<person name="Ovelleiro D."/>
<person name="Casas V."/>
<person name="Gay M."/>
<person name="Abian J."/>
</authorList>
<dbReference type="PubMed" id="19367720"/>
<dbReference type="DOI" id="10.1021/pr800500r"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-113</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>T-cell</tissue>
</source>
</reference>
<reference key="23">
<citation type="journal article" date="2008" name="Proteomics" volume="8" first="1346" last="1361">
<title>Large-scale phosphoproteome analysis of human liver tissue by enrichment and fractionation of phosphopeptides with strong anion exchange chromatography.</title>
<authorList>
<person name="Han G."/>
<person name="Ye M."/>
<person name="Zhou H."/>
<person name="Jiang X."/>
<person name="Feng S."/>
<person name="Jiang X."/>
<person name="Tian R."/>
<person name="Wan D."/>
<person name="Zou H."/>
<person name="Gu J."/>
</authorList>
<dbReference type="PubMed" id="18318008"/>
<dbReference type="DOI" id="10.1002/pmic.200700884"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-113</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="24">
<citation type="journal article" date="2009" name="Antiinflamm. Antiallergy Agents Med. Chem." volume="8" first="290" last="305">
<title>Anti-infective protective properties of S100 calgranulins.</title>
<authorList>
<person name="Hsu K."/>
<person name="Champaiboon C."/>
<person name="Guenther B.D."/>
<person name="Sorenson B.S."/>
<person name="Khammanivong A."/>
<person name="Ross K.F."/>
<person name="Geczy C.L."/>
<person name="Herzberg M.C."/>
</authorList>
<dbReference type="PubMed" id="20523765"/>
<dbReference type="DOI" id="10.2174/187152309789838975"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2009" name="Biochem. J." volume="422" first="363" last="372">
<title>A novel p53 target gene, S100A9, induces p53-dependent cellular apoptosis and mediates the p53 apoptosis pathway.</title>
<authorList>
<person name="Li C."/>
<person name="Chen H."/>
<person name="Ding F."/>
<person name="Zhang Y."/>
<person name="Luo A."/>
<person name="Wang M."/>
<person name="Liu Z."/>
</authorList>
<dbReference type="PubMed" id="19534726"/>
<dbReference type="DOI" id="10.1042/bj20090465"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2009" name="Eur. J. Pharmacol." volume="625" first="73" last="83">
<title>S100A8/A9: a Janus-faced molecule in cancer therapy and tumorgenesis.</title>
<authorList>
<person name="Ghavami S."/>
<person name="Chitayat S."/>
<person name="Hashemi M."/>
<person name="Eshraghi M."/>
<person name="Chazin W.J."/>
<person name="Halayko A.J."/>
<person name="Kerkhoff C."/>
</authorList>
<dbReference type="PubMed" id="19835859"/>
<dbReference type="DOI" id="10.1016/j.ejphar.2009.08.044"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2009" name="FEMS Immunol. Med. Microbiol." volume="55" first="55" last="61">
<title>Substitution of methionine 63 or 83 in S100A9 and cysteine 42 in S100A8 abrogate the antifungal activities of S100A8/A9: potential role for oxidative regulation.</title>
<authorList>
<person name="Sroussi H.Y."/>
<person name="Koehler G.A."/>
<person name="Agabian N."/>
<person name="Villines D."/>
<person name="Palefsky J.M."/>
</authorList>
<dbReference type="PubMed" id="19087201"/>
<dbReference type="DOI" id="10.1111/j.1574-695x.2008.00498.x"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>MUTAGENESIS OF MET-63; MET-81 AND MET-83</scope>
<scope>INHIBITION BY ZINC IONS</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="7078" last="7090">
<title>Calprotectin S100A9 calcium-binding loops I and II are essential for keratinocyte resistance to bacterial invasion.</title>
<authorList>
<person name="Champaiboon C."/>
<person name="Sappington K.J."/>
<person name="Guenther B.D."/>
<person name="Ross K.F."/>
<person name="Herzberg M.C."/>
</authorList>
<dbReference type="PubMed" id="19122197"/>
<dbReference type="DOI" id="10.1074/jbc.m806605200"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>MUTAGENESIS OF GLU-36 AND GLU-78</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2009" name="J. Leukoc. Biol." volume="86" first="557" last="566">
<title>The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer.</title>
<authorList>
<person name="Ehrchen J.M."/>
<person name="Sunderkoetter C."/>
<person name="Foell D."/>
<person name="Vogl T."/>
<person name="Roth J."/>
</authorList>
<dbReference type="PubMed" id="19451397"/>
<dbReference type="DOI" id="10.1189/jlb.1008647"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2009" name="PLoS Biol." volume="7" first="E97" last="E97">
<title>Identification of human S100A9 as a novel target for treatment of autoimmune disease via binding to quinoline-3-carboxamides.</title>
<authorList>
<person name="Bjoerk P."/>
<person name="Bjoerk A."/>
<person name="Vogl T."/>
<person name="Stenstroem M."/>
<person name="Liberg D."/>
<person name="Olsson A."/>
<person name="Roth J."/>
<person name="Ivars F."/>
<person name="Leanderson T."/>
</authorList>
<dbReference type="PubMed" id="19402754"/>
<dbReference type="DOI" id="10.1371/journal.pbio.1000097"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>SUBUNIT</scope>
<scope>INTERACTION WITH TLR4; LY96 AND AGER</scope>
<scope>QUINOLINE-3-CARBOXAMIDE BINDING</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2010" name="Cell Res." volume="20" first="314" last="331">
<title>S100A8/A9 induces autophagy and apoptosis via ROS-mediated cross-talk between mitochondria and lysosomes that involves BNIP3.</title>
<authorList>
<person name="Ghavami S."/>
<person name="Eshragi M."/>
<person name="Ande S.R."/>
<person name="Chazin W.J."/>
<person name="Klonisch T."/>
<person name="Halayko A.J."/>
<person name="McNeill K.D."/>
<person name="Hashemi M."/>
<person name="Kerkhoff C."/>
<person name="Los M."/>
</authorList>
<dbReference type="PubMed" id="19935772"/>
<dbReference type="DOI" id="10.1038/cr.2009.129"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2010" name="Immunol. Cell Biol." volume="88" first="41" last="49">
<title>S100 Calgranulins in inflammatory arthritis.</title>
<authorList>
<person name="Perera C."/>
<person name="McNeil H.P."/>
<person name="Geczy C.L."/>
</authorList>
<dbReference type="PubMed" id="19935766"/>
<dbReference type="DOI" id="10.1038/icb.2009.88"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2010" name="J. Leukoc. Biol." volume="87" first="905" last="914">
<title>Induction of neutrophil degranulation by S100A9 via a MAPK-dependent mechanism.</title>
<authorList>
<person name="Simard J.C."/>
<person name="Girard D."/>
<person name="Tessier P.A."/>
</authorList>
<dbReference type="PubMed" id="20103766"/>
<dbReference type="DOI" id="10.1189/jlb.1009676"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-113</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="35">
<citation type="journal article" date="2011" name="Amino Acids" volume="41" first="821" last="842">
<title>Inflammation-associated S100 proteins: new mechanisms that regulate function.</title>
<authorList>
<person name="Goyette J."/>
<person name="Geczy C.L."/>
</authorList>
<dbReference type="PubMed" id="20213444"/>
<dbReference type="DOI" id="10.1007/s00726-010-0528-0"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2011" name="J. Immunol." volume="186" first="3622" last="3631">
<title>Damage-associated molecular pattern S100A9 increases bactericidal activity of human neutrophils by enhancing phagocytosis.</title>
<authorList>
<person name="Simard J.C."/>
<person name="Simon M.M."/>
<person name="Tessier P.A."/>
<person name="Girard D."/>
</authorList>
<dbReference type="PubMed" id="21325622"/>
<dbReference type="DOI" id="10.4049/jimmunol.1002956"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2012" name="Arterioscler. Thromb. Vasc. Biol." volume="32" first="223" last="229">
<title>S100A8 and S100A9 in cardiovascular biology and disease.</title>
<authorList>
<person name="Averill M.M."/>
<person name="Kerkhoff C."/>
<person name="Bornfeldt K.E."/>
</authorList>
<dbReference type="PubMed" id="22095980"/>
<dbReference type="DOI" id="10.1161/atvbaha.111.236927"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2012" name="Immunology" volume="137" first="172" last="182">
<title>Induction of nuclear factor-kappaB responses by the S100A9 protein is Toll-like receptor-4-dependent.</title>
<authorList>
<person name="Riva M."/>
<person name="Kaellberg E."/>
<person name="Bjoerk P."/>
<person name="Hancz D."/>
<person name="Vogl T."/>
<person name="Roth J."/>
<person name="Ivars F."/>
<person name="Leanderson T."/>
</authorList>
<dbReference type="PubMed" id="22804476"/>
<dbReference type="DOI" id="10.1111/j.1365-2567.2012.03619.x"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2012" name="Inflammation" volume="35" first="409" last="419">
<title>Dynamic mobility of immunological cells expressing S100A8 and S100A9 in vivo: a variety of functional roles of the two proteins as regulators in acute inflammatory reaction.</title>
<authorList>
<person name="Koike A."/>
<person name="Arai S."/>
<person name="Yamada S."/>
<person name="Nagae A."/>
<person name="Saita N."/>
<person name="Itoh H."/>
<person name="Uemoto S."/>
<person name="Totani M."/>
<person name="Ikemoto M."/>
</authorList>
<dbReference type="PubMed" id="21487906"/>
<dbReference type="DOI" id="10.1007/s10753-011-9330-8"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2012" name="Int. J. Mol. Sci." volume="13" first="2893" last="2917">
<title>Pro-inflammatory S100A8 and S100A9 proteins: self-assembly into multifunctional native and amyloid complexes.</title>
<authorList>
<person name="Vogl T."/>
<person name="Gharibyan A.L."/>
<person name="Morozova-Roche L.A."/>
</authorList>
<dbReference type="PubMed" id="22489132"/>
<dbReference type="DOI" id="10.3390/ijms13032893"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2012" name="J. Innate Immun." volume="4" first="31" last="40">
<title>S100A8 and S100A9: new insights into their roles in malignancy.</title>
<authorList>
<person name="Srikrishna G."/>
</authorList>
<dbReference type="PubMed" id="21912088"/>
<dbReference type="DOI" id="10.1159/000330095"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2012" name="PLoS ONE" volume="7" first="E40277" last="E40277">
<title>Molecular interface of S100A8 with cytochrome b and NADPH oxidase activation.</title>
<authorList>
<person name="Berthier S."/>
<person name="Nguyen M.V."/>
<person name="Baillet A."/>
<person name="Hograindleur M.A."/>
<person name="Paclet M.H."/>
<person name="Polack B."/>
<person name="Morel F."/>
</authorList>
<dbReference type="PubMed" id="22808130"/>
<dbReference type="DOI" id="10.1371/journal.pone.0040277"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH CYBA AND CYBB</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2012" name="PLoS ONE" volume="7" first="E32953" last="E32953">
<title>MRP14 (S100A9) protein interacts with Alzheimer beta-amyloid peptide and induces its fibrillization.</title>
<authorList>
<person name="Zhang C."/>
<person name="Liu Y."/>
<person name="Gilthorpe J."/>
<person name="van der Maarel J.R."/>
</authorList>
<dbReference type="PubMed" id="22457725"/>
<dbReference type="DOI" id="10.1371/journal.pone.0032953"/>
</citation>
<scope>INTERACTION WITH APP</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2012" name="PLoS ONE" volume="7" first="E29333" last="E29333">
<title>Constitutive neutrophil apoptosis: regulation by cell concentration via S100 A8/9 and the MEK-ERK pathway.</title>
<authorList>
<person name="Atallah M."/>
<person name="Krispin A."/>
<person name="Trahtemberg U."/>
<person name="Ben-Hamron S."/>
<person name="Grau A."/>
<person name="Verbovetski I."/>
<person name="Mevorach D."/>
</authorList>
<dbReference type="PubMed" id="22363402"/>
<dbReference type="DOI" id="10.1371/journal.pone.0029333"/>
</citation>
<scope>FUNCTION</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2014" name="Cell" volume="159" first="623" last="634">
<title>Target-selective protein S-nitrosylation by sequence motif recognition.</title>
<authorList>
<person name="Jia J."/>
<person name="Arif A."/>
<person name="Terenzi F."/>
<person name="Willard B."/>
<person name="Plow E.F."/>
<person name="Hazen S.L."/>
<person name="Fox P.L."/>
</authorList>
<dbReference type="PubMed" id="25417112"/>
<dbReference type="DOI" id="10.1016/j.cell.2014.09.032"/>
</citation>
<scope>FUNCTION</scope>
<scope>ASSEMBLY IN THE INOS-S100A8/A9 COMPLEX</scope>
<scope>MUTAGENESIS OF CYS-3</scope>
<scope>S-NITROSYLATION AT CYS-3</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-113</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="48">
<citation type="journal article" date="2002" name="J. Mol. Biol." volume="316" first="265" last="276">
<title>The crystal structure of human MRP14 (S100A9), a Ca(2+)-dependent regulator protein in inflammatory process.</title>
<authorList>
<person name="Itou H."/>
<person name="Yao M."/>
<person name="Fujita I."/>
<person name="Watanabe N."/>
<person name="Suzuki M."/>
<person name="Nishihira J."/>
<person name="Tanaka I."/>
</authorList>
<dbReference type="PubMed" id="11851337"/>
<dbReference type="DOI" id="10.1006/jmbi.2001.5340"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) IN COMPLEX WITH CALCIUM IONS</scope>
<scope>MASS SPECTROMETRY</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2007" name="J. Mol. Biol." volume="370" first="887" last="898">
<title>The crystal structure of the human (S100A8/S100A9)2 heterotetramer, calprotectin, illustrates how conformational changes of interacting alpha-helices can determine specific association of two EF-hand proteins.</title>
<authorList>
<person name="Korndoerfer I.P."/>
<person name="Brueckner F."/>
<person name="Skerra A."/>
</authorList>
<dbReference type="PubMed" id="17553524"/>
<dbReference type="DOI" id="10.1016/j.jmb.2007.04.065"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 4-114 IN COMPLEX WITH S100A8</scope>
<scope>SUBUNIT</scope>
<scope>ZINC-BINDING</scope>
</reference>
<comment type="function">
<text evidence="12 13 14 15 17 20 21 22 23 24 25 26 27 28 30 31 33 36">S100A9 is a calcium- and zinc-binding protein which plays a prominent role in the regulation of inflammatory processes and immune response. It can induce neutrophil chemotaxis, adhesion, can increase the bactericidal activity of neutrophils by promoting phagocytosis via activation of SYK, PI3K/AKT, and ERK1/2 and can induce degranulation of neutrophils by a MAPK-dependent mechanism. Predominantly found as calprotectin (S100A8/A9) which has a wide plethora of intra- and extracellular functions. The intracellular functions include: facilitating leukocyte arachidonic acid trafficking and metabolism, modulation of the tubulin-dependent cytoskeleton during migration of phagocytes and activation of the neutrophilic NADPH-oxidase. Activates NADPH-oxidase by facilitating the enzyme complex assembly at the cell membrane, transferring arachidonic acid, an essential cofactor, to the enzyme complex and S100A8 contributes to the enzyme assembly by directly binding to NCF2/P67PHOX. The extracellular functions involve proinflammatory, antimicrobial, oxidant-scavenging and apoptosis-inducing activities. Its proinflammatory activity includes recruitment of leukocytes, promotion of cytokine and chemokine production, and regulation of leukocyte adhesion and migration. Acts as an alarmin or a danger associated molecular pattern (DAMP) molecule and stimulates innate immune cells via binding to pattern recognition receptors such as Toll-like receptor 4 (TLR4) and receptor for advanced glycation endproducts (AGER). Binding to TLR4 and AGER activates the MAP-kinase and NF-kappa-B signaling pathways resulting in the amplification of the proinflammatory cascade. Has antimicrobial activity towards bacteria and fungi and exerts its antimicrobial activity probably via chelation of Zn(2+) which is essential for microbial growth. Can induce cell death via autophagy and apoptosis and this occurs through the cross-talk of mitochondria and lysosomes via reactive oxygen species (ROS) and the process involves BNIP3. Can regulate neutrophil number and apoptosis by an anti-apoptotic effect; regulates cell survival via ITGAM/ITGB and TLR4 and a signaling mechanism involving MEK-ERK. Its role as an oxidant scavenger has a protective role in preventing exaggerated tissue damage by scavenging oxidants. Can act as a potent amplifier of inflammation in autoimmunity as well as in cancer development and tumor spread. Has transnitrosylase activity; in oxidatively-modified low-densitity lipoprotein (LDL(ox))-induced S-nitrosylation of GAPDH on 'Cys-247' proposed to transfer the NO moiety from NOS2/iNOS to GAPDH via its own S-nitrosylated Cys-3. The iNOS-S100A8/A9 transnitrosylase complex is proposed to also direct selective inflammatory stimulus-dependent S-nitrosylation of multiple targets such as ANXA5, EZR, MSN and VIM by recognizing a [IL]-x-C-x-x-[DE] motif.</text>
</comment>
<comment type="subunit">
<text evidence="7 10 11 13 15 17 18 19 20 21 22 29 31 33 36 37 40">Homodimer. Preferentially exists as a heterodimer or heterotetramer with S100A8 known as calprotectin (S100A8/A9). S100A9 interacts with ATP2A2 (By similarity). S100A9 interacts with AGER, and with the heterodimeric complex formed by TLR4 and LY96 in the presence of calcium and/or zinc ions. S100A9 binds quinoline-3-carboxamides in the presence of calcium and/or zinc ions. S100A9 interacts with amyloid-beta protein 40. Calprotectin (S100A8/9) interacts with CEACAM3 and tubulin filaments in a calcium-dependent manner. Heterotetrameric calprotectin (S100A8/A9) interacts with ANXA6 and associates with tubulin filaments in activated monocytes. Calprotectin (S100A8/9) interacts with NCF2/P67PHOX, RAC1, RAC2, CYBA and CYBB. Calprotectin (S100A8/9) interacts with NOS2 to form the iNOS-S100A8/A9 transnitrosylase complex; induced by LDL(ox) (PubMed:25417112).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1055001">
<id>P06702</id>
</interactant>
<interactant intactId="EBI-743313">
<id>P49407</id>
<label>ARRB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1055001">
<id>P06702</id>
</interactant>
<interactant intactId="EBI-714559">
<id>P32121</id>
<label>ARRB2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1055001">
<id>P06702</id>
</interactant>
<interactant intactId="EBI-3906571">
<id>P20138</id>
<label>CD33</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1055001">
<id>P06702</id>
</interactant>
<interactant intactId="EBI-740978">
<id>P43355</id>
<label>MAGEA1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1055001">
<id>P06702</id>
</interactant>
<interactant intactId="EBI-5651459">
<id>P43357</id>
<label>MAGEA3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1055001">
<id>P06702</id>
</interactant>
<interactant intactId="EBI-1045155">
<id>P43360</id>
<label>MAGEA6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1055001">
<id>P06702</id>
</interactant>
<interactant intactId="EBI-355281">
<id>P05109</id>
<label>S100A8</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1055001">
<id>P06702</id>
</interactant>
<interactant intactId="EBI-458391">
<id>P04271</id>
<label>S100B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Secreted</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
<location>Cytoskeleton</location>
</subcellularLocation>
<subcellularLocation>
<location>Cell membrane</location>
<topology>Peripheral membrane protein</topology>
</subcellularLocation>
<text>Predominantly localized in the cytoplasm. Upon elevation of the intracellular calcium level, translocated from the cytoplasm to the cytoskeleton and the cell membrane. Upon neutrophil activation or endothelial adhesion of monocytes, is secreted via a microtubule-mediated, alternative pathway.</text>
</comment>
<comment type="tissue specificity">
<text evidence="14 34 35 36 37">Calprotectin (S100A8/9) is predominantly expressed in myeloid cells. Except for inflammatory conditions, the expression is restricted to a specific stage of myeloid differentiation since both proteins are expressed in circulating neutrophils and monocytes but are absent in normal tissue macrophages and lymphocytes. Under chronic inflammatory conditions, such as psoriasis and malignant disorders, also expressed in the epidermis. Found in high concentrations at local sites of inflammation or in the serum of patients with inflammatory diseases such as rheumatoid, cystic fibrosis, inflammatory bowel disease, Crohn's disease, giant cell arteritis, cystic fibrosis, Sjogren's syndrome, systemic lupus erythematosus, and progressive systemic sclerosis. Involved in the formation and deposition of amyloids in the aging prostate known as corpora amylacea inclusions. Strongly up-regulated in many tumors, including gastric, esophageal, colon, pancreatic, bladder, ovarian, thyroid, breast and skin cancers.</text>
</comment>
<comment type="PTM">
<text evidence="13 16 32">Phosphorylated. Phosphorylation inhibits activation of tubulin polymerization.</text>
</comment>
<comment type="PTM">
<text evidence="40">S-nitrosylation of Cys-3 is implicated in LDL(ox)-induced S-nitrosylation of GAPDH at 'Cys-247' through a transnitrosylase mechanism involving a iNOS-S100A8/9 complex (PubMed:25417112).</text>
</comment>
<comment type="mass spectrometry" mass="13115" method="MALDI" evidence="11"/>
<comment type="similarity">
<text evidence="39">Belongs to the S-100 family.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/S100A9ID45569ch1q21.html"/>
</comment>
<dbReference type="EMBL" id="X06233">
<property type="protein sequence ID" value="CAA29579.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M21064">
<property type="protein sequence ID" value="AAA36326.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M26311">
<property type="protein sequence ID" value="AAA68480.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF237581">
<property type="protein sequence ID" value="AAF62536.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF237582">
<property type="protein sequence ID" value="AAF62537.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CR542207">
<property type="protein sequence ID" value="CAG47003.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CR542224">
<property type="protein sequence ID" value="CAG47020.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL591704">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471121">
<property type="protein sequence ID" value="EAW53333.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471121">
<property type="protein sequence ID" value="EAW53334.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC047681">
<property type="protein sequence ID" value="AAH47681.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS1036.1"/>
<dbReference type="PIR" id="B31848">
<property type="entry name" value="B31848"/>
</dbReference>
<dbReference type="RefSeq" id="NP_002956.1">
<property type="nucleotide sequence ID" value="NM_002965.3"/>
</dbReference>
<dbReference type="PDB" id="1IRJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A/B/C/D/E/F/G/H=2-114"/>
</dbReference>
<dbReference type="PDB" id="1XK4">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="C/D/G/H/K/L=2-114"/>
</dbReference>
<dbReference type="PDB" id="4GGF">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.60"/>
<property type="chains" value="C/L/T/V=1-114"/>
</dbReference>
<dbReference type="PDB" id="4XJK">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.76"/>
<property type="chains" value="B/D/F/H/J=1-114"/>
</dbReference>
<dbReference type="PDB" id="5I8N">
<property type="method" value="NMR"/>
<property type="chains" value="A/B=1-114"/>
</dbReference>
<dbReference type="PDB" id="5W1F">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="B/D/F/H=1-114"/>
</dbReference>
<dbReference type="PDB" id="6DS2">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="B/D/F/H=1-114"/>
</dbReference>
<dbReference type="PDBsum" id="1IRJ"/>
<dbReference type="PDBsum" id="1XK4"/>
<dbReference type="PDBsum" id="4GGF"/>
<dbReference type="PDBsum" id="4XJK"/>
<dbReference type="PDBsum" id="5I8N"/>
<dbReference type="PDBsum" id="5W1F"/>
<dbReference type="PDBsum" id="6DS2"/>
<dbReference type="SMR" id="P06702"/>
<dbReference type="BioGRID" id="112188">
<property type="interactions" value="136"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-37">
<property type="entry name" value="Calprotectin heterotetramer"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-39">
<property type="entry name" value="Calprotectin heterodimer"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-48">
<property type="entry name" value="S100A9 complex"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-52">
<property type="entry name" value="iNOS-S100A8/A9 complex"/>
</dbReference>
<dbReference type="CORUM" id="P06702"/>
<dbReference type="DIP" id="DIP-1166N"/>
<dbReference type="IntAct" id="P06702">
<property type="interactions" value="48"/>
</dbReference>
<dbReference type="MINT" id="P06702"/>
<dbReference type="STRING" id="9606.ENSP00000357727"/>
<dbReference type="BindingDB" id="P06702"/>
<dbReference type="DrugBank" id="DB01373">
<property type="generic name" value="Calcium"/>
</dbReference>
<dbReference type="DrugBank" id="DB01593">
<property type="generic name" value="Zinc"/>
</dbReference>
<dbReference type="DrugBank" id="DB14487">
<property type="generic name" value="Zinc acetate"/>
</dbReference>
<dbReference type="DrugBank" id="DB14533">
<property type="generic name" value="Zinc chloride"/>
</dbReference>
<dbReference type="DrugBank" id="DB14548">
<property type="generic name" value="Zinc sulfate, unspecified form"/>
</dbReference>
<dbReference type="iPTMnet" id="P06702"/>
<dbReference type="MetOSite" id="P06702"/>
<dbReference type="PhosphoSitePlus" id="P06702"/>
<dbReference type="SwissPalm" id="P06702"/>
<dbReference type="BioMuta" id="S100A9"/>
<dbReference type="DMDM" id="115444"/>
<dbReference type="OGP" id="P06702"/>
<dbReference type="SWISS-2DPAGE" id="P06702"/>
<dbReference type="UCD-2DPAGE" id="P06702"/>
<dbReference type="CPTAC" id="CPTAC-1294"/>
<dbReference type="CPTAC" id="CPTAC-1295"/>
<dbReference type="CPTAC" id="non-CPTAC-1155"/>
<dbReference type="EPD" id="P06702"/>
<dbReference type="jPOST" id="P06702"/>
<dbReference type="MassIVE" id="P06702"/>
<dbReference type="MaxQB" id="P06702"/>
<dbReference type="PaxDb" id="P06702"/>
<dbReference type="PeptideAtlas" id="P06702"/>
<dbReference type="PRIDE" id="P06702"/>
<dbReference type="ProteomicsDB" id="51910"/>
<dbReference type="TopDownProteomics" id="P06702"/>
<dbReference type="Antibodypedia" id="1084">
<property type="antibodies" value="1172 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000368738">
<property type="protein sequence ID" value="ENSP00000357727"/>
<property type="gene ID" value="ENSG00000163220"/>
</dbReference>
<dbReference type="GeneID" id="6280"/>
<dbReference type="KEGG" id="hsa:6280"/>
<dbReference type="UCSC" id="uc001fbq.3">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="6280"/>
<dbReference type="DisGeNET" id="6280"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000163220.10"/>
<dbReference type="GeneCards" id="S100A9"/>
<dbReference type="HGNC" id="HGNC:10499">
<property type="gene designation" value="S100A9"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000163220">
<property type="expression patterns" value="Tissue enhanced (blood, bone marrow, esophagus, tongue)"/>
</dbReference>
<dbReference type="MIM" id="123886">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P06702"/>
<dbReference type="OpenTargets" id="ENSG00000163220"/>
<dbReference type="PharmGKB" id="PA34911"/>
<dbReference type="eggNOG" id="ENOG502SA01">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000161606"/>
<dbReference type="HOGENOM" id="CLU_138624_6_0_1"/>
<dbReference type="InParanoid" id="P06702"/>
<dbReference type="KO" id="K21128"/>
<dbReference type="OMA" id="NTFHHYS"/>
<dbReference type="OrthoDB" id="1521098at2759"/>
<dbReference type="PhylomeDB" id="P06702"/>
<dbReference type="TreeFam" id="TF332727"/>
<dbReference type="PathwayCommons" id="P06702"/>
<dbReference type="Reactome" id="R-HSA-5668599">
<property type="pathway name" value="RHO GTPases Activate NADPH Oxidases"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5686938">
<property type="pathway name" value="Regulation of TLR by endogenous ligand"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6798695">
<property type="pathway name" value="Neutrophil degranulation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6799990">
<property type="pathway name" value="Metal sequestration by antimicrobial proteins"/>
</dbReference>
<dbReference type="SIGNOR" id="P06702"/>
<dbReference type="BioGRID-ORCS" id="6280">
<property type="hits" value="7 hits in 873 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="S100A9">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P06702"/>
<dbReference type="GeneWiki" id="S100A9"/>
<dbReference type="GenomeRNAi" id="6280"/>
<dbReference type="Pharos" id="P06702">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:P06702"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 1"/>
</dbReference>
<dbReference type="RNAct" id="P06702">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000163220">
<property type="expression patterns" value="Expressed in ectocervix and 199 other tissues"/>
</dbReference>
<dbReference type="Genevisible" id="P06702">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0030054">
<property type="term" value="C:cell junction"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0062023">
<property type="term" value="C:collagen-containing extracellular matrix"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005856">
<property type="term" value="C:cytoskeleton"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005576">
<property type="term" value="C:extracellular region"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005615">
<property type="term" value="C:extracellular space"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034774">
<property type="term" value="C:secretory granule lumen"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0016209">
<property type="term" value="F:antioxidant activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0050544">
<property type="term" value="F:arachidonic acid binding"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005509">
<property type="term" value="F:calcium ion binding"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008017">
<property type="term" value="F:microtubule binding"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050786">
<property type="term" value="F:RAGE receptor binding"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035662">
<property type="term" value="F:Toll-like receptor 4 binding"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008270">
<property type="term" value="F:zinc ion binding"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006919">
<property type="term" value="P:activation of cysteine-type endopeptidase activity involved in apoptotic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0061844">
<property type="term" value="P:antimicrobial humoral immune response mediated by antimicrobial peptide"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019730">
<property type="term" value="P:antimicrobial humoral response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006915">
<property type="term" value="P:apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0006914">
<property type="term" value="P:autophagy"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007267">
<property type="term" value="P:cell-cell signaling"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0032602">
<property type="term" value="P:chemokine production"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001816">
<property type="term" value="P:cytokine production"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042742">
<property type="term" value="P:defense response to bacterium"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050832">
<property type="term" value="P:defense response to fungus"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0002523">
<property type="term" value="P:leukocyte migration involved in inflammatory response"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035821">
<property type="term" value="P:modulation of process of other organism"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070488">
<property type="term" value="P:neutrophil aggregation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030593">
<property type="term" value="P:neutrophil chemotaxis"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043312">
<property type="term" value="P:neutrophil degranulation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0035606">
<property type="term" value="P:peptidyl-cysteine S-trans-nitrosylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030307">
<property type="term" value="P:positive regulation of cell growth"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050729">
<property type="term" value="P:positive regulation of inflammatory response"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2001244">
<property type="term" value="P:positive regulation of intrinsic apoptotic signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010976">
<property type="term" value="P:positive regulation of neuron projection development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051092">
<property type="term" value="P:positive regulation of NF-kappaB transcription factor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051493">
<property type="term" value="P:regulation of cytoskeleton organization"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032119">
<property type="term" value="P:sequestering of zinc ion"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002224">
<property type="term" value="P:toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="InterPro" id="IPR011992">
<property type="entry name" value="EF-hand-dom_pair"/>
</dbReference>
<dbReference type="InterPro" id="IPR018247">
<property type="entry name" value="EF_Hand_1_Ca_BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR002048">
<property type="entry name" value="EF_hand_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR028475">
<property type="entry name" value="S100-A9"/>
</dbReference>
<dbReference type="InterPro" id="IPR001751">
<property type="entry name" value="S100/CaBP-9k_CS"/>
</dbReference>
<dbReference type="InterPro" id="IPR013787">
<property type="entry name" value="S100_Ca-bd_sub"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11639:SF79">
<property type="entry name" value="PTHR11639:SF79"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01023">
<property type="entry name" value="S_100"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00054">
<property type="entry name" value="EFh"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM01394">
<property type="entry name" value="S_100"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF47473">
<property type="entry name" value="SSF47473"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00018">
<property type="entry name" value="EF_HAND_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50222">
<property type="entry name" value="EF_HAND_2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00303">
<property type="entry name" value="S100_CABP"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0929">Antimicrobial</keyword>
<keyword id="KW-0049">Antioxidant</keyword>
<keyword id="KW-0053">Apoptosis</keyword>
<keyword id="KW-0072">Autophagy</keyword>
<keyword id="KW-0106">Calcium</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0145">Chemotaxis</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0206">Cytoskeleton</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0395">Inflammatory response</keyword>
<keyword id="KW-0399">Innate immunity</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0488">Methylation</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0702">S-nitrosylation</keyword>
<keyword id="KW-0964">Secreted</keyword>
<keyword id="KW-0862">Zinc</keyword>
<feature type="chain" description="Protein S100-A9" id="PRO_0000143997">
<location>
<begin position="1"/>
<end position="114"/>
</location>
</feature>
<feature type="domain" description="EF-hand 1" evidence="9">
<location>
<begin position="12"/>
<end position="47"/>
</location>
</feature>
<feature type="domain" description="EF-hand 2" evidence="9">
<location>
<begin position="54"/>
<end position="89"/>
</location>
</feature>
<feature type="calcium-binding region" description="1; low affinity">
<location>
<begin position="23"/>
<end position="36"/>
</location>
</feature>
<feature type="calcium-binding region" description="2; high affinity" evidence="39">
<location>
<begin position="67"/>
<end position="78"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc" evidence="39">
<location>
<position position="20"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc" evidence="39">
<location>
<position position="30"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc" evidence="39">
<location>
<position position="91"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc" evidence="39">
<location>
<position position="95"/>
</location>
</feature>
<feature type="modified residue" description="Blocked amino end (Thr)">
<location>
<position position="2"/>
</location>
</feature>
<feature type="modified residue" description="S-nitrosocysteine; transient" evidence="40">
<location>
<position position="3"/>
</location>
</feature>
<feature type="modified residue" description="Pros-methylhistidine" evidence="8">
<location>
<position position="105"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by MAPK14" evidence="3 4 5 6 13 16 32">
<location>
<position position="113"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_013008" evidence="38">
<original>H</original>
<variation>R</variation>
<location>
<position position="20"/>
</location>
</feature>
<feature type="mutagenesis site" description="Disrupts interaction with NOS2 and inhibits LDL(ox)-induced GAPDH S-nitrosylation; no effect on interaction with S100A8." evidence="33">
<original>C</original>
<variation>A</variation>
<location>
<position position="3"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of resistance to bacterial invasion; when associated with Q-78." evidence="21">
<original>E</original>
<variation>Q</variation>
<location>
<position position="36"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of antifungal activity." evidence="20">
<original>M</original>
<variation>A</variation>
<location>
<position position="63"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of resistance to bacterial invasion; when associated with Q-36." evidence="21">
<original>E</original>
<variation>Q</variation>
<location>
<position position="78"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on antifungal activity." evidence="20">
<original>M</original>
<variation>A</variation>
<location>
<position position="81"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of antifungal activity." evidence="20">
<original>M</original>
<variation>A</variation>
<location>
<position position="83"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 12; AA sequence." ref="12" evidence="39">
<original>S</original>
<variation>H</variation>
<location>
<position position="6"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 12; AA sequence." ref="12" evidence="39">
<original>K</original>
<variation>F</variation>
<location>
<position position="25"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 12; AA sequence." ref="12" evidence="39">
<original>H</original>
<variation>L</variation>
<location>
<position position="28"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="7"/>
<end position="23"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="25"/>
<end position="28"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="34"/>
<end position="44"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="45"/>
<end position="49"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="50"/>
<end position="53"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="56"/>
<end position="66"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="71"/>
<end position="74"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="76"/>
<end position="94"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="95"/>
<end position="97"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="108"/>
<end position="110"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4GGF"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5I8N"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18318008"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19367720"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000250"/>
<evidence key="8" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P50116"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00448"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11708798"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11851337"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12626582"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15331440"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15598812"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15642721"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15905572"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16258195"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17553524"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18786929"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19087201"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19122197"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19402754"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19534726"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19935772"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20103766"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21325622"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21487906"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22363402"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22457725"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22804476"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22808130"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2478889"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25417112"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="3313057"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="3405210"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8423249"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9083090"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source ref="4"/>
</evidence>
<evidence key="39" type="ECO:0000305"/>
<evidence key="40" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="25417112"/>
</source>
</evidence>
<sequence length="114" mass="13242" checksum="C3BE19729E14C078" modified="1988-01-01" version="1">MTCKMSQLERNIETIINTFHQYSVKLGHPDTLNQGEFKELVRKDLQNFLKKENKNEKVIEHIMEDLDTNADKQLSFEEFIMLMARLTWASHEKMHEGDEGPGHHHKPGLGEGTP</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

